IO Biotech, Inc.
NASDAQ:IOBT
1.19 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 1.11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.214 | 0.211 | 0.201 | 0.194 | 0.187 | 0.174 | 0.19 | 0.119 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.214 | -0.211 | 0.909 | -0.194 | -0.187 | -0.174 | -0.19 | -0.119 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.819 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 15.848 | 14.311 | 21.77 | 17.655 | 16.504 | 11.9 | 14.433 | 10.022 | 12.226 | 10.306 | 16.44 | 4.128 | 6.735 | 2.848 | 2.21 | 2.777 | 1.738 | 1.738 |
| General & Administrative Expenses
| 5.685 | 5.886 | 6.413 | 5.829 | 5.348 | 6.024 | 5.955 | 5.843 | 5.935 | 6.704 | 4.955 | 2.914 | 2.248 | 0.965 | 0.329 | 0.654 | 0.35 | 0.35 |
| Selling & Marketing Expenses
| -0.214 | 0 | -0.201 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.471 | 5.886 | 6.212 | 5.829 | 5.348 | 6.024 | 5.955 | 5.843 | 5.935 | 6.704 | 4.955 | 2.914 | 2.248 | 0.965 | 0.329 | 0.654 | 0.35 | 0.35 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.295 | 2.63 | -29.46 | 0 | -0.028 | -0.041 | 0 | 0 |
| Operating Expenses
| 21.319 | 20.197 | 27.982 | 23.484 | 21.852 | 17.924 | 20.388 | 15.865 | 18.161 | 17.01 | 21.395 | 7.042 | 8.983 | 3.813 | 2.539 | 3.431 | 2.996 | 2.996 |
| Operating Income
| -21.533 | -20.197 | -28.183 | -23.484 | -21.852 | -17.924 | -20.388 | -15.865 | -18.161 | -17.01 | -21.395 | -7.042 | -8.983 | -3.813 | -2.539 | -3.431 | -2.088 | -2.088 |
| Operating Income Ratio
| 0 | 0 | -25.39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.221 | 1.155 | 2.354 | -0.342 | 0.01 | 1.286 | 1.303 | 0.292 | -0.23 | -0.128 | 0.305 | 2.647 | -29.305 | 0.137 | -0.004 | -0.05 | -0.913 | -0.913 |
| Income Before Tax
| -20.312 | -19.042 | -25.829 | -22.118 | -20.646 | -16.638 | -19.085 | -15.573 | -18.391 | -17.138 | -21.241 | -4.462 | -38.359 | -3.748 | -2.554 | -3.488 | -3 | -3 |
| Income Before Tax Ratio
| 0 | 0 | -23.269 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.374 | 0.415 | 0.353 | -0.439 | 0.532 | 0.406 | 0.987 | 0.115 | 0.104 | 0.066 | 0.068 | 0.067 | 0.071 | -3.741 | 0.011 | 0.007 | -0.913 | -0.913 |
| Net Income
| -20.686 | -19.457 | -26.182 | -21.679 | -21.178 | -17.044 | -20.072 | -15.688 | -18.495 | -17.204 | -21.309 | -4.462 | -38.359 | -3.748 | -2.554 | -3.488 | -3.511 | -3.511 |
| Net Income Ratio
| 0 | 0 | -23.587 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.31 | -0.3 | -0.4 | -0.43 | -0.73 | -0.59 | -0.7 | -0.54 | -0.64 | -0.6 | -0.83 | -0.17 | -3.32 | -0.32 | -0.22 | -0.3 | -19.83 | -19.83 |
| EPS Diluted
| -0.31 | -0.3 | -0.4 | -0.43 | -0.73 | -0.59 | -0.7 | -0.54 | -0.64 | -0.6 | -0.83 | -0.17 | -3.32 | -0.32 | -0.22 | -0.3 | -19.81 | -19.81 |
| EBITDA
| -21.319 | -20.197 | -27.982 | -21.776 | -20.469 | -16.722 | -19.606 | -15.289 | -17.992 | -16.775 | -21.1 | -4.412 | -38.443 | -3.813 | -2.567 | -3.472 | -1.423 | -1.423 |
| EBITDA Ratio
| 0 | 0 | -25.209 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |